469 related articles for article (PubMed ID: 8420443)
1. Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients.
McDonald GB; Hinds MS; Fisher LD; Schoch HG; Wolford JL; Banaji M; Hardin BJ; Shulman HM; Clift RA
Ann Intern Med; 1993 Feb; 118(4):255-67. PubMed ID: 8420443
[TBL] [Abstract][Full Text] [Related]
2. Incidence and outcome of hepatic veno-occlusive disease after blood or marrow transplantation: a prospective cohort study of the European Group for Blood and Marrow Transplantation. European Group for Blood and Marrow Transplantation Chronic Leukemia Working Party.
Carreras E; Bertz H; Arcese W; Vernant JP; Tomás JF; Hagglund H; Bandini G; Esperou H; Russell J; de la Rubia J; Di Girolamo G; Demuynck H; Hartmann O; Clausen J; Ruutu T; Leblond V; Iriondo A; Bosi A; Ben-Bassat I; Koza V; Gratwohl A; Apperley JF
Blood; 1998 Nov; 92(10):3599-604. PubMed ID: 9808553
[TBL] [Abstract][Full Text] [Related]
3. Veno-occlusive disease of the liver after allogeneic bone marrow transplantation in children with hematologic malignancies: incidence, onset time and risk factors.
Hasegawa S; Horibe K; Kawabe T; Kato K; Kojima S; Matsuyama T; Hirabayashi N
Bone Marrow Transplant; 1998 Dec; 22(12):1191-7. PubMed ID: 9894723
[TBL] [Abstract][Full Text] [Related]
4. Veno-occlusive disease of the liver after busulfan, melphalan, and thiotepa conditioning therapy: incidence, risk factors, and outcome.
Lee JL; Gooley T; Bensinger W; Schiffman K; McDonald GB
Biol Blood Marrow Transplant; 1999; 5(5):306-15. PubMed ID: 10534061
[TBL] [Abstract][Full Text] [Related]
5. Hepatic veno-occlusive disease--liver toxicity syndrome after bone marrow transplantation.
Shulman HM; Hinterberger W
Bone Marrow Transplant; 1992 Sep; 10(3):197-214. PubMed ID: 1422475
[TBL] [Abstract][Full Text] [Related]
6. Intravenous immunoglobulin and the risk of hepatic veno-occlusive disease after bone marrow transplantation.
Sullivan KM; Kansu E; Storer B; Jocom J; Emerson G; Reagan T; Emerson V; Siadak MF; Davis C; Appelbaum FR; Buckner CD; Hansen JA; Shulman HM; Storb R; McDonald GB
Biol Blood Marrow Transplant; 1998; 4(1):20-6. PubMed ID: 9701388
[TBL] [Abstract][Full Text] [Related]
7. Phase II trial of heparin prophylaxis for veno-occlusive disease of the liver in children undergoing bone marrow transplantation.
Rosenthal J; Sender L; Secola R; Killen R; Millerick M; Murphy L; Cairo MS
Bone Marrow Transplant; 1996 Jul; 18(1):185-91. PubMed ID: 8832013
[TBL] [Abstract][Full Text] [Related]
8. Risk factors for hepatic veno-occlusive disease following HLA-identical sibling bone marrow transplants for leukemia.
Rozman C; Carreras E; Qian C; Gale RP; Bortin MM; Rowlings PA; Ash RC; Champlin RE; Henslee-Downey PJ; Herzig RH; Hinterberger W; Klein JP; Prentice HG; Reiffers J; Zwaan FE; Horowitz MM
Bone Marrow Transplant; 1996 Jan; 17(1):75-80. PubMed ID: 8673059
[TBL] [Abstract][Full Text] [Related]
9. Hepatic dysfunction following busulfan and cyclophosphamide myeloablation: a retrospective, multicenter analysis.
Styler MJ; Crilley P; Biggs J; Moul J; Copelan E; Topolsky D; Avalos B; Penza S; Sabol P; Downs K; Szer J; Brodsky I; Marks DI
Bone Marrow Transplant; 1996 Jul; 18(1):171-6. PubMed ID: 8832011
[TBL] [Abstract][Full Text] [Related]
10. Venoocclusive disease of the liver: development of a model for predicting fatal outcome after marrow transplantation.
Bearman SI; Anderson GL; Mori M; Hinds MS; Shulman HM; McDonald GB
J Clin Oncol; 1993 Sep; 11(9):1729-36. PubMed ID: 8355040
[TBL] [Abstract][Full Text] [Related]
11. Hepatic veno-occlusive disease post-bone marrow transplantation in children conditioned with busulfan and cyclophosphamide: incidence, risk factors, and clinical outcome.
Ozkaynak MF; Weinberg K; Kohn D; Sender L; Parkman R; Lenarsky C
Bone Marrow Transplant; 1991 Jun; 7(6):467-74. PubMed ID: 1908340
[TBL] [Abstract][Full Text] [Related]
12. A prospective survey on incidence, risk factors and therapy of hepatic veno-occlusive disease in children after hematopoietic stem cell transplantation.
Cesaro S; Pillon M; Talenti E; Toffolutti T; Calore E; Tridello G; Strugo L; Destro R; Gazzola MV; Varotto S; Errigo G; Carli M; Zanesco L; Messina C
Haematologica; 2005 Oct; 90(10):1396-404. PubMed ID: 16219577
[TBL] [Abstract][Full Text] [Related]
13. Defibrotide for Treatment of Severe Veno-Occlusive Disease in Pediatrics and Adults: An Exploratory Analysis Using Data from the Center for International Blood and Marrow Transplant Research.
Strouse C; Richardson P; Prentice G; Korman S; Hume R; Nejadnik B; Horowitz MM; Saber W
Biol Blood Marrow Transplant; 2016 Jul; 22(7):1306-1312. PubMed ID: 27108694
[TBL] [Abstract][Full Text] [Related]
14. Association of pulmonary function testing abnormalities and severe veno-occlusive disease of the liver after marrow transplantation.
Matute-Bello G; McDonald GD; Hinds MS; Schoch HG; Crawford SW
Bone Marrow Transplant; 1998 Jun; 21(11):1125-30. PubMed ID: 9645575
[TBL] [Abstract][Full Text] [Related]
15. Veno-occlusive disease of the liver following high-dose chemotherapy and autologous bone marrow transplantation in children with solid tumors: incidence, clinical course and outcome.
Brugieres L; Hartmann O; Benhamou E; Zafrani ES; Caillaud JM; Patte C; Kalifa C; Flamant F; Lemerle J
Bone Marrow Transplant; 1988 Jan; 3(1):53-8. PubMed ID: 3048471
[TBL] [Abstract][Full Text] [Related]
16. Related donor liver transplant for veno-occlusive disease following T-depleted unrelated donor bone marrow transplantation.
Bunin N; Leahey A; Dunn S
Transplantation; 1996 Feb; 61(4):664-6. PubMed ID: 8610401
[TBL] [Abstract][Full Text] [Related]
17. Norethisterone treatment, a major risk-factor for veno-occlusive disease in the liver after allogeneic bone marrow transplantation.
Hägglund H; Remberger M; Klaesson S; Lönnqvist B; Ljungman P; Ringdén O
Blood; 1998 Dec; 92(12):4568-72. PubMed ID: 9845522
[TBL] [Abstract][Full Text] [Related]
18. Liver disease is a major cause of mortality following allogeneic bone-marrow transplantation.
El-Sayed MH; El-Haddad A; Fahmy OA; Salama II; Mahmoud HK
Eur J Gastroenterol Hepatol; 2004 Nov; 16(12):1347-54. PubMed ID: 15618844
[TBL] [Abstract][Full Text] [Related]
19. Risk factors for hepatic veno-occlusive disease after bone marrow transplantation: retrospective analysis of 137 cases at a single institution.
Kami M; Mori S; Tanikawa S; Akiyama H; Onozawa Y; Tanaka T; Okamoto R; Maeda Y; Sasaki T; Kaku H; Matsuura Y; Hiruma K; Sakamaki H
Bone Marrow Transplant; 1997 Sep; 20(5):397-402. PubMed ID: 9339756
[TBL] [Abstract][Full Text] [Related]
20. Frequency of veno-occlusive disease of the liver in bone marrow transplantation with a modified busulfan/cyclophosphamide preparative regimen.
Brodsky R; Topolsky D; Crilley P; Bulova S; Brodsky I
Am J Clin Oncol; 1990 Jun; 13(3):221-5. PubMed ID: 2346127
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
